AAO: Triple Therapy Leads to Lasting Improvement in Macular Degeneration

Medpage Today

NEW ORLEANS, Nov. 13 -- For many patients with choroidal neovascularization from age-related macular degeneration, a single cycle of photodynamic therapy, bevacizumab (Avastin), and intravitreal steroids led to sustained improvement in visual acuity, German investigators reported here.
  • <<
  • >>

Comments